Travatan (travoprost) eye drops 40 mcg/ml. 2.5 ml. vial

$44.00

Manufacturer:

Purpose: Reduces intraocular pressure by increasing fluid drainage in glaucoma treatment.

SKU: MED61728 Category:

Description

Travatan (travoprost) Eye Drops 40 mcg/ml. 2.5 ml Vial

Ingredients

Travatan eye drops contain travoprost 40 mcg/ml as the active ingredient.

Dosage

The recommended dosage is one drop in the affected eye(s) once daily in the evening.

Indications

Travatan eye drops are indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Contraindications

Do not use Travatan eye drops if you are allergic to travoprost or any other ingredients in the formulation.

Directions

Administer one drop into the conjunctival sac of the affected eye(s) once daily in the evening.

Scientific Evidence

Travatan (travoprost) has been extensively studied in clinical trials for its efficacy in reducing intraocular pressure. Research published in the Journal of Ocular Pharmacology and Therapeutics demonstrated that travoprost is effective in lowering intraocular pressure in patients with glaucoma. The prostaglandin analog travoprost works by increasing uveoscleral outflow, thereby reducing intraocular pressure.

Additional Information

It is important to use Travatan eye drops regularly as prescribed by your healthcare provider to achieve the best results in managing your glaucoma or ocular hypertension. Remember to keep the vial tightly closed when not in use and store it at room temperature away from moisture and heat.

Pharmacological Effects: Travatan (travoprost) is a prostaglandin analog that works by increasing the outflow of aqueous humor from the eye, thereby reducing intraocular pressure. This mechanism of action helps in the management of conditions such as glaucoma and ocular hypertension.

Comparative Effectiveness: Studies have shown that travoprost, the active ingredient in Travatan eye drops, is as effective as other prostaglandin analogs in lowering intraocular pressure. In comparative trials, travoprost has demonstrated similar efficacy with potentially fewer side effects, making it a favorable choice for many patients.